GAMMA Investing’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
GAMMA Investing's TVTX Position: Q3 2026 in Review
GAMMA Investing increased its Travere Therapeutics (TVTX) stake by 115% in Q3 2026, buying an estimated $42.6K and bringing the position to 1,303 shares worth $76.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2070.
GAMMA Investing first reported a position in TVTX in Q1 2024 and has held it in 11 quarters since. 251 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- GAMMA Investing held 1,303 shares of Travere Therapeutics worth $76.7K as of Q3 2026.
- GAMMA Investing bought 697 Travere Therapeutics shares in Q3 2026, an estimated $42.6K.
- Travere Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2070 holding.
- GAMMA Investing first reported a position in Travere Therapeutics in Q1 2024 and has held it in 11 quarters since.
- 251 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.